Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.
about
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell PopulationsNK Cells in HIV DiseaseInborn errors of the development of human natural killer cellsPrimary immunodeficiency update: Part II. Syndromes associated with mucocutaneous candidiasis and noninfectious cutaneous manifestationsGenetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell SubsetsNK Cell Influence on the Outcome of Primary Epstein-Barr Virus InfectionDysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during DiseasesHarnessing adaptive natural killer cells in cancer immunotherapyTranscriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells.NK cells and virus-related cancers.Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.Haematopoietic and immune defects associated with GATA2 mutation.GATA2 deficiency underlying severe blastomycosis and fatal herpes simplex virus-associated hemophagocytic lymphohistiocytosisA genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.Human Cytokine-Induced Memory-Like Natural Killer Cells.Association of GATA2 Deficiency With Severe Primary Epstein-Barr Virus (EBV) Infection and EBV-associated Cancers.Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).Biallelic mutations in IRF8 impair human NK cell maturation and functionAcquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation.GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.The evolution of cellular deficiency in GATA2 mutationNatural killer cell deficiency.Clonal tracking of rhesus macaque hematopoiesis highlights a distinct lineage origin for natural killer cellsNatural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.Clinical utility of natural killer cells in cancer therapy and transplantation.Cytokine immunomodulation for the treatment of infectious diseases: lessons from primary immunodeficiencies.Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer.How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future.Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections.Transcriptional and post-transcriptional regulation of NK cell development and function.Human CD56bright NK Cells: An Update.Emerging insights into natural killer cells in human peripheral tissues.Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cellsNK cells in host responses to viral infections.Role of Distinct Natural Killer Cell Subsets in Anticancer Response.Acquired Senescent T-Cell Phenotype Correlates with Clinical Severity in GATA Binding Protein 2-Deficient Patients.Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations.Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms.Subacute demyelinating polyradiculoneuropathy complicating Epstein-Barr virus infection in GATA2 haploinsufficiency.Resolution of Multifocal Epstein-Barr Virus-Related Smooth Muscle Tumor in a Patient with GATA2 Deficiency Following Hematopoietic Stem Cell Transplantation.
P2860
Q26742158-7E2F238A-5A71-4E1B-8C8A-A69A30268EA8Q26752833-36B7398C-AFDC-4A31-AC84-51D9FDD5B3D2Q26827686-4195A455-CB0F-4E2A-B388-2948236A55BAQ26830870-A2ED6075-B479-4925-AFE7-B6766317725FQ28067993-E683DA8A-1742-4187-BE4E-E0F36550F166Q28069456-DCD5E078-0B74-4C92-90E0-3553902F02C1Q28079140-FE5CB216-68C1-428F-A365-BC7F4FD430DAQ28081448-99B8B0D4-D648-4DBA-A441-EADC556C68FEQ33799561-66C1B007-AF25-42BB-B84A-CD7D4867A2D5Q34337237-45053567-D4A5-4752-8790-0ABC3FF4E39EQ35510477-D11EB259-53EA-4301-86A8-658D47D38C8FQ35535835-B4BA5C9F-A6FA-4254-B061-F6413275EADDQ36563645-26F2D836-CDFF-450C-B7ED-8FD81D2B7177Q36654943-C1FED031-D2A4-4562-9CAC-29651A35B605Q36830628-43472299-C31D-4B20-ADD0-7CFAE5C7ACCAQ36991772-2111349D-B114-49A2-BD36-56329BBD5191Q37047952-7F2C078B-0E5C-44DE-9BD9-7E863D7C267AQ37545040-7D8E105C-D9C6-4CD1-8B91-F3AF15734D66Q37552020-089EBFE5-3F80-428A-957F-26DFBD2B0B31Q37564756-670B1F30-CF62-4B93-848A-1BA1AB1F9A20Q37564769-63907ED4-4A15-421A-8F62-2A6F8CE7270BQ37567421-A638C4E1-CB84-49F7-86C3-47E2C45C1A88Q37691796-9C938065-5075-4532-A159-B30F09C42006Q38169654-F23ED9D7-2588-4DD9-B7E0-B05205042D6AQ38195120-0BF94DA1-B724-475F-B464-5243FF4020BAQ38216460-7189C557-AE48-4110-9A4B-316C93BDC96DQ38233046-CC2406A8-B5E4-4873-9A55-E585AC33F9A7Q38432092-221BBDC3-D592-4672-87D7-11CFC9C09F32Q38637282-BB43BEB2-2DB0-413D-97FE-76DD33495915Q38763233-D45A090F-451A-44E7-852E-79D18450D3B3Q38781384-CF5398EE-7408-481D-8326-20C6CF615D60Q38819280-5C2A921C-FFC0-4241-927C-7190C913D3C0Q38956465-D0C0D84A-86DC-42CB-80F8-B37054DACFAFQ39041518-36E8C66D-F87B-458A-A8AF-7D83216D23B7Q39210022-F331B7C2-5B54-4CCB-B617-FDDF45E133E8Q40106850-2CCE2995-34F5-4A09-BF10-B4F43A864B9AQ40165095-47B06C97-3A3E-456B-A783-1CF2DBBAF0D3Q40331582-DB18662C-3D94-4807-9B18-6025C487BC69Q40369647-F56E1F4B-DF4A-42B8-B413-184D1EB583EBQ40421062-7522EA7F-5858-4097-9D7E-5EE007D894D8
P2860
Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mutations in GATA2 cause human ...... ss of the CD56(bright) subset.
@ast
Mutations in GATA2 cause human ...... ss of the CD56(bright) subset.
@en
type
label
Mutations in GATA2 cause human ...... ss of the CD56(bright) subset.
@ast
Mutations in GATA2 cause human ...... ss of the CD56(bright) subset.
@en
prefLabel
Mutations in GATA2 cause human ...... ss of the CD56(bright) subset.
@ast
Mutations in GATA2 cause human ...... ss of the CD56(bright) subset.
@en
P2093
P2860
P50
P1433
P1476
Mutations in GATA2 cause human ...... oss of the CD56(bright) subset
@en
P2093
Christa S Zerbe
Christine A Biron
Christine Spalding
Eugene P Frenkel
George Makedonas
Jeffrey I Cohen
John C Bagwell
John L Sullivan
Joshua B Rosen
Lesia Dropulic
P2860
P304
P356
10.1182/BLOOD-2012-09-453969
P407
P577
2013-01-30T00:00:00Z